The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Bristol-Myers Squibb Co

NYSE: BMY
Last

(U.S.) $61.30

Today's change+0.51 +0.84%
Updated December 19 4:10 PM EST. Delayed by at least 15 minutes.
 

Bristol-Myers Squibb Co

NYSE: BMY
Last

(U.S.) $61.30

Today's change+0.51 +0.84%
Updated December 19 4:10 PM EST. Delayed by at least 15 minutes.

Bristol-Myers Squibb Co Hits New 52-week High

Bristol-Myers Squibb Co closed up Friday by (U.S.)$0.51 or 0.84% to (U.S.)$61.30 and setting a new 52-week high. Over the last five days, shares have gained 4.34% and 15.33% year to date. Shares have performed in-line with the S&P 500 during the last year.

Key company metrics

  • Open(U.S.) $60.84
  • Previous close(U.S.) $60.79
  • High(U.S.) $61.64
  • Low(U.S.) $60.60
  • Bid / Ask-- / --
  • YTD % change+15.33%
  • Volume10,975,053
  • Average volume (10-day)6,676,569
  • Average volume (1-month)6,030,255
  • Average volume (3-month)6,880,116
  • 52-week range(U.S.) $46.30 to (U.S.) $61.64
  • Beta0.33
  • Trailing P/E37.65×
  • P/E 1 year forward33.76×
  • Forward PEG2.81×
  • Indicated annual dividend(U.S.) $1.48
  • Dividend yield2.41%
  • Trailing EPS(U.S.) $1.63
Updated December 19 4:10 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+17.04%

Based on its net profit margin of 17.04%, Bristol-Myers Squibb Co is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.85%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue3,9213,8893,8114,441
Total other revenue--------
Total revenue3,9213,8893,8114,441
Gross profit2,9502,9372,8883,168
Total cost of revenue9719529231,273
Total operating expense3,2103,4493,0903,586
Selling / general / administrative1,2001,1381,1201,322
Research & development918958898957
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)19253820766
Other operating expenses, total-71-137-58-32
Operating income711440721855
Interest income (expense), net non-operating-50-46-54-53
Gain (loss) on sale of assets315-72591
Other--------
Income before tax1,008448985869
Income after tax732334936735
Income tax, total27611449134
Net income721333937726
Total adjustments to net income------0
Net income before extra. items721333937726
Minority interest-11-11-9
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items721333937726
Inc. avail. to common incl. extra. items721333937726
Diluted net income721333937726
Dilution adjustment--------
Diluted weighted average shares1,6701,6691,6661,671
Diluted EPS excluding extraordinary itemsvalue per share0.430.200.560.43
Dividends per sharevalue per share0.360.360.360.35
Diluted normalized EPSvalue per share0.350.580.600.36